Cargando…
Rhenium Perrhenate ((188)ReO(4)) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells
Recurrence in hepatocellular carcinoma (HCC) after conventional treatments is a crucial challenge. Despite the promising progress in advanced targeted therapies, HCC is the fourth leading cause of cancer death worldwide. Radionuclide therapy can potentially be a practical targeted approach to addres...
Autores principales: | Asadian, Samieh, Piryaei, Abbas, Gheibi, Nematollah, Aziz Kalantari, Bagher, Reza Davarpanah, Mohamad, Azad, Mehdi, Kapustina, Valentina, Alikhani, Mehdi, Moghbeli Nejad, Sahar, Keshavarz Alikhani, Hani, Mohamadi, Morteza, Shpichka, Anastasia, Timashev, Peter, Hassan, Moustapha, Vosough, Massoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774126/ https://www.ncbi.nlm.nih.gov/pubmed/35053421 http://dx.doi.org/10.3390/cells11020305 |
Ejemplares similares
-
(188)Rhenium Treatment Induces DACT2 Expression in Hepatocellular
Carcinoma Cells
por: Asadian, Samieh, et al.
Publicado: (2022) -
Thermal Analysis of Benzotriazolium Perrhenate and
Its Implication to Rhenium Metal
por: Louis-Jean, James, et al.
Publicado: (2021) -
μ-Hydroxido-bis[(2,2′-bipyridine)tricarbonylrhenium(I)] perrhenate
por: Ruth, Kai, et al.
Publicado: (2008) -
Theoretical Prediction of Rhenium Separation from
Ammonium Perrhenate by Phonon–Photon Resonance Absorption
por: Li, Miao-Miao, et al.
Publicado: (2022) -
Rhenium 188: The Poor Man's Yttrium
por: Shinto, Ajit
Publicado: (2017)